Morales-Viveros M, Jardón-Reyes A

Language: Spanish
References: 10
Page: 152-158
PDF size: 531.46 Kb.

ABSTRACT

Background: The metabolic syndrome is the set of disturbances, which includes: central obesity, decreased high-density cholesterol (HDL-C), elevated triglycerides, systemic hypertension and hyperglycemia. In Mexico there is no evidence on the record of metabolic syndrome in children.
Objective: To identify the clinical and biochemical markers of risk of metabolic syndrome in 12-16 years old adolescents.
Material and method: An observational, prospective, transversal and descriptive study was done at Telesecundaria Ricardo Flores Magón, located in Estado de México. The universe of the sample included 50 men and 51 women. We obtained data about: medical history, blood pressure, body mass index, acne, acanthosis nigricans and capillary glucose.
Results: In clinical and biochemical indicators considered risk factors of metabolic syndrome, parameters according to sex were highlighted and in male subjects obesity was reported in 5 (11%), acanthosis nigricans in 15 (30%), acne in 7 (14%), altered capillary glucose in 9 (18%) and altered blood pressure in 6 (13%). While in female obesity was found in 9 (17%), altered blood pressure in 9 (17%), acne in 4 (7.8%), acanthosis nigricans in 13 (25%) and altered capillary glucose in 7 (13%).
Conclusions: There are increasingly larger numbers of factors contributing to the development of metabolic syndrome. The minimal search of these factors among children favors the delayed diagnosis and its complications. Therefore, preventive measures are important to detect this type of illness in adolescents, who because of their age, represent the future of Mexico.

REFERENCES

1. Bautista SL, Saldaña CM, Hernández PJ. Síndrome metabólico en población de 6-16 años de edad en primer nivel de atención. Revista de la Facultad de Medicina de la UNAM 2010;53.

2. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición. México 2012;88-90,168-170.

3. Kauffer HM, Toussaint G. Indicadores antropométricos para evaluar sobrepeso y obesidad en pediatría. Bol Med Hosp Infantil Mex 2008;65:502-515.

4. Córdova VJA, Barriguete MJA, Rivera MME, Manuell LG, Mancha MC. Sobrepeso y obesidad. Situación actual y perspectivas. Acta Médica Grupo Ángeles 2010;8:203-206.

5. Alberti KGMM, Zimmet PZ, Shaw JE. The metabolic syndrome a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006;23:469-480.

6. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the atherosclerosis, hypertension, and obesity in the Young Committee (Council on cardiovascular in the young) and the Diabetes Committee (Council on Nutrition, Physical Activity and Metabolism). Circulation 2003;107:1448-1453.

7. Katzmarzyk PT, Pérusse L, Malina RM, Bergeron J, et al. Stability of indicators of metabolic syndrome from childhood and adolescence to young adult: the Québec Family Study. J Clin Epidemiol 2001;54:190-195.

8. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. National high blood pressure education program working group on high blood pressure in children and adolescents. Official journal of the American Academy of Pediatrics. Disponible en: http://pediatrics.aappublications. org/cgi/reprint/114/2/s2/555

9. Weiss R, Dziura J, Burgert T, Tamborlane W, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-2374.

10. Cárdenas-Villareal VM y col. Prevalencia de síndrome metabólico en adolescentes. Arch Cardiol Mex 2010;80:19-26.